DEA CS Code Numbers - Nov 12, 2026 - 7362 (Plant & Resin), 7353 (Extract), 7386 (Natural THC)

DEA - Proposed APQs for 2027 - Federal Register - Nov 10, 2026

A separate notice will be published in the Federal Register once the proposed APQs for the schedule III substances (drug codes 7362, 7353, 7386) are determined.






Hawaii Constitution - Article I - Section 5 - Due Process and Equal Protection: No person shall be deprived of life, liberty or property without due process of law, nor be denied the equal protection of the laws, nor be denied the enjoyment of the person’s civil rights or be discriminated against in the exercise thereof because of race, religion, sex or ancestry.

Act 219 (1988) - Act 386 (1989) - Act 387 (1989)


41 U.S.C. 12111(6) - Illegal Use of Drugs

(A)  In general - The term “illegal use of drugs” means the use of drugs, the possession or distribution of which is unlawful under the Controlled Substances Act [21 U.S.C. 801 et seq.]. Such term does not include the use of a drug taken under supervision by a licensed health care professional, or other uses authorized by the Controlled Substances Act or other provisions of Federal law.


DEA - Medical Marijuana Timely Applicants

DEA Medical Marijuana Timely Applicant Information

Timely Applicants and DEA registrants may not lawfully engage in any schedule III medical marijuana activities with entities that did not complete an application for DEA registration between April 28, 2026, to June 26, 2026, or that have not applied for a DEA schedule III medical marijuana registration, until those entities become DEA registrants.

DOJ - Federal Registrations for Medical Marijuana Dispensaries - Oct 30, 2026

Hawaii Dispensary Timely Applicants (Retail Locations) as of Oct 30, 2026 = 14

Total Retail Locations: Oahu = 11, Maui = 5, Hawaii = 6, Kauai = 2










“Last year, regulators began double checking the work of licensed testing labs to catch potential problems with mold, pesticides and other contaminants.”

















"The final decision rests with the TSA officer on whether an item is allowed through the checkpoint."

TSA - What Can I Bring - Medical Marijuana - Apr 27, 2026

GSA - TSA On-Airport Leasing - 2010

“Public law requires the airport authority or owner to provide security checkpoint screening areas to TSA free of charge.”

43 CFR 2911 - Airport Leases





Patient Experiences and Access Barriers - Wilkins, et al - May, 2026

In New York State, geographic inaccessibility of medical dispensaries and the high costs of certification and cannabis products are central barriers to medical cannabis program participation.


Plenty of us never sat in the seat you are in, never made a payroll or lost a harvest to a rule we wrote. We are still on your side. We want you to make it, and we do not want you to fail, whatever you have heard about us. We will also hand you a hard truth now and then and hold you to the curfew, because this only works as long as we remain a society of laws.


State cannabis regulators and officials in several states, including Oklahoma, Vermont and Washington, told Stateline they are waiting for guidance from the DEA and other federal agencies before determining whether businesses will be required to register with the DEA, qualify for federal tax relief or face new compliance requirements, and whether states may need to revise their own cannabis laws.





HNL TSA OFFICE

Under Federal law and many State laws, it is a crime to possess or transport any detectable amount of marijuana. TSA does not have any regulations that address the possession or transportation of marijuana and certain cannabis infused products. However, we are required to notify law enforcement officers if we discover marijuana, drug paraphernalia, or other items that are illegal under State and Federal laws, while screening you and your accessible property.

Products or medications that contain hemp-derived CBD oil or are FDA approved are legal and permitted in carry-on or checked baggage as long as it is produced within the regulations defined by the law under the Agriculture Improvement Act 2018.

Having a State-issued cannabis card or other documentation indicating that the marijuana is for medical purposes does not exempt you from TSA's requirement to notify law enforcement.  It is up to the responding officer, not TSA, to determine if possession of the marijuana is authorized under State law, or whether to make an arrest or confiscate the item if it is illegal.

FAA - Rulemaking Stakeholder Feedback Form





HRS 329-11 - Authority to schedule controlled substances

(d)  If a substance is added, deleted, or rescheduled as a controlled substance under federal law and notice of the designation is given to the department of law enforcement, the department of law enforcement shall recommend that a corresponding change in Hawaii law be made.  The department of law enforcement shall similarly designate the substance as added, deleted, or rescheduled under this chapter, after the expiration of thirty days from publication in the Federal Register of a final order, and this change shall have the effect of law.



Chapter 329 - Hawaii UCSA

§329-33  Registration. (d) Compliance by manufacturers and distributors with the provisions of the federal law respecting registration (excluding fees) entitles them to be registered under this chapter.

§329D-1  Definitions. "Manufacture" means the preparation, propagation, compounding, conversion, or processing of a substance containing cannabis or its principal psychoactive constituent tetrahydrocannabinol, either directly or indirectly, by a person other than a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient for the qualifying patient's or qualifying out-of-state patient's use, by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the substance or labeling or relabeling of its container.

§329D-9  Manufacturing of medical cannabis products.  (a)  Any medical cannabis dispensary licensed by the department pursuant to this chapter shall be permitted to manufacture cannabis products; provided that the dispensary shall also obtain any other state or county permits or licenses that may be necessary for a particular manufacturing activity.








PART 1308 - SCHEDULES OF CONTROLLED SUBSTANCES - 21 CFR 1308.13 - Schedule III

(g) Hallucinogenic substances.

(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product—7369. [Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol]

(2) Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license—XXXX

(3) Marijuana extract, as defined in 21 CFR 1308.11(d)(58), in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license—XXXX

(4) Naturally derived delta-9-tetrahydrocannabinols in a U.S. Food and Drug Administration approved product or in marijuana subject to a state medical marijuana license—XXXX

(i) Naturally derived delta-9-tetrahydrocannabinols means those delta-9-tetrahydrocannabinols, except as in paragraphs (g)(2) and (3) of this section, that are naturally contained in a plant of the genus Cannabis (cannabis plant).

(ii) Naturally derived delta-9-tetrahydrocannabinols do not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o.

(iii) Naturally derived delta-9-tetrahydrocannabinols do not include any delta-9-tetrahydrocannabinols contained in substances excluded from the definition of marijuana as set forth in 21 U.S.C. 802(16)(B)(ii).


Federal Register - DEA - Marijuana Rescheduling - Final Rule - Apr 28, 2026

21 CFR 1301.13 - Application for Registration - (k) Medical Marijuana Registrations

Section 5. Prescriptions. Notwithstanding part 1306 of this chapter or any other provision of these rules, a certification or other document (including an electronic document) that state law deems sufficient for a user to obtain marijuana or products containing marijuana for medical purposes shall be sufficient to permit dispensing of marijuana or products containing marijuana to a user so long as the certification or other document is dated as of, and signed on, the day when issued; bears the full name and address of the user; and contains the name, address, and state license number of the practitioner who signed the certification or other document and is authorized to do so under state law.





DEA - Medical Marijuana Dispensary Submission Instructions

Section 4: Liability Questions - Has anyone who will be involved in the ownership or operation of the firm previously manufactured, distributed, and/or dispensed any controlled substance without a DEA registration authorizing such activity?




21 CFR 1301.13(k) - The Administrator shall register an applicant under this subsection unless the Administrator determines that the issuance of such registration is inconsistent with the public interest, taking into account the factors set forth at 21 U.S.C. 823(e)-(g), as applicable, and the requirements of the Single Convention on Narcotic Drugs, including any quota requirement.

21 USC 823 - Registration requirements

AP - Trump Reclassifies State-licensed Medical Marijuana - Apr 23, 2026




SCR64 - Requesting Congress to Deschedule Cannabis

STATES 2.0 ACT - Joyce, Miller, Titus - Apr 17, 2025

(b) Drugs.—A marijuana product meeting the definition of a drug shall be treated as a drug for purposes of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.).

21 U.S. Code Chapter 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT




Hawaii Medicare Patients: 315,000, Hawaii Medicaid Patients: 429,000, Registered Medical Cannabis Patients: 30,000, Potential Medical Cannabis Patients: 260,000

Medical Cannabis Use and Healthcare Utilization - Doucette, et al - 2025

Medical Cannabis Laws Lower Insurance Premiums - Cook, et al - 2023




What Rescheduling Would Mean - Rowe, et al - 2026

Rescheduling would not legalize cannabis at the federal level, authorize interstate commerce, or confer FDA approval on existing products. State-legal cannabis would remain federally unlawful unless specific statutory exemptions or FDA approval pathways are in place.


CRS - The Federal Status of Marijuana and The Policy Gap with States - Mar 10, 2026

Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical marijuana industry into compliance with the CSA. If marijuana were moved to Schedule III, it could theoretically be used for medical purposes consistent with federal law. However, Schedule III controlled substances may only legally be dispensed pursuant to a valid prescription and, as discussed below, marijuana is not currently a prescription drug approved by the Food and Drug Administration (FDA).


2026 Resolutions

HCR170 - Reharmonizing Medical Cannabis - Referred to HTH

SCR150 - Reharmonizing Medical Cannabis - Passed through HHS as is




NBC News - Supreme Court leans toward challenge to gun restriction - Mar 2, 2026

CNN - Marijuana Advocates Light Up Second Amendment Fight - Mar 1, 2026

Gun Control Act of 1968 - 18 USC 922(g)(3)

(g) It shall be unlawful for any person (3) who is an unlawful user of or addicted to marihuana or any depressant or stimulant drug (as defined in section 201 (v) of the Federal Food, Drug, and Cosmetic Act) or narcotic drug (as defined in section 4731(a) of the Internal Revenue Code of 1954) to ship or transport any firearm or ammunition in interstate or foreign commerce.

21 USC 802 - Definitions - Addict

The term “addict” means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction.

US v. Hemani - US Supreme Court - Docket No. 24-1234

ATF - 27 CFR 478.11 - Unlawful User - As of Jan 22, 2026

ATF - 27 CFR 478.11 - Unlawful User - Prior to Jan 22, 2026

91 FR 2698 - Jan 22, 2026 - DOJ - ATF - Interim Final Rule - Unlawful User






“So I think we got more votes from our internal polling but it’s not enough. So I still need to keep working on it” - Rep. Tarnas


“The federal government takes the position that if you work in the field or a dispensary, you are a drug trafficker”










2026 CJS Appropriations Act - Jan 23, 2026

Sec. 531. None of the funds made available under this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, the Commonwealth of the Northern Mariana Islands, the United States Virgin Islands, Guam, or Puerto Rico, to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.







NEW BILLS

HB1542 - Hawaii Ryan’s Law - Never heard by CPC

HB1624 - Constitutional Amendment - Never heard by JHA/CPC, FIN

HB1625 - Adult Use Legalization - Never heard by JHA/AGR, CPC, FIN

HB1856 - Repeal Bad Language - Never heard by HLT, JHA

SB2178 - Industrial Hemp - Waiting on AGR/WAL

SB2274 - Repeal Bad Language - Waiting on JDC

SB2408 - Hawaii Ryan’s Law - Deferred by JHA

SB2413 - Dispensary Seeds - Waiting on JDC/WAM

SB2418 - Repeal Drug Paraphernalia Law - Final House Vote

SB2420 - Constitutional Amendment - Never heard by JDC, WAM

SB2421 - Adult Use Legalization - Deferred by CPN/HHS

SB2998 - Employment Protections - Never heard by HHS/LBT, JDC/CPN

SB3206 - Hemp THC Limits - Deferred by HHS/CPN

SB3275 - Low Potency Legalization - Never heard by WAM/JDC

SB3315 - One Time Purchase - Waiting on HLT

NEW RESOLUTIONS

HCR170 - Reharmonizing State and Federal Law - Never heard by HLT

SCR64 - Requesting Congress to De-schedule Cannabis - Referred to JHA, CPC

SCR150 - Reharmonizing State and Federal Law - Never heard by JDC

CARRY OVER BILLS

HB814 - Education and Prevention - Waiting on FIN


“The rule of law is not self-executing — it depends on our collective commitment to apply it.”




ARCHIVES




















































































































































































































































































“Marijuana remains popular and in abundance in Hawaii, and with the development of legalized medical marijuana dispensaries and efforts for full legalization, it is anticipated that Hawaii will mirror the ramifications of legalized marijuana as in the state of Colorado: black market marijuana production and distribution will flourish in Hawaii, children will be using marijuana at a younger age and illicit outdoor marijuana cultivation will prevail in the remote areas of the Hawaiian Islands.”

Fusion Centers and HIDTA Investigative Support Centers









“The Task Force concludes that neither a federal crackdown nor a hands-off approach is advisable. In the absence of cannabis rescheduling, or its legalization at the federal level, the Task Force recommends that Congress and the Administration develop a state waiver process or contractual framework. Without it, states and the industry will continue to exist under an illusion of sovereignty where circumstances can change at any moment. A balanced and thoughtful accommodation from the federal government would provide confidence to states, stabilize the market, and help address many of the myriad safety and health problems.”

THE HILL - Judiciary - Marc Levin - April 6, 2022




“The bill, sponsored by Democratic Rep. Jerry Nadler of New York, will prevent federal agencies from denying federal workers security clearances for cannabis use, and will allow the Veterans' Administration to recommend medical marijuana to veterans living with posttraumatic stress disorder, plus gains revenue by authorizing a sales tax on marijuana sales.”

The federal Bureau of Labor Statistics shall maintain a national public database of all business owners and individuals who are employed in the cannabis industry.



HACDACS 2021 Report to the Legislature - December 31, 2021

Page 16: "HACDACS recommends pursuing all available options for protecting Hawaii’s medical cannabis patients from legal repercussions related to the federal prohibition and current Federal scheduling of Cannabis as a schedule 1 drug. An advisory group consisting of representatives from involved state and local agencies, the medical community, the medical cannabis industry and community groups may provide added resources and expertise to help solve this difficult problem."



“The medical community agrees that we need more research to learn about marijuana’s potential health benefits, but our federal laws today are standing in the way of us finding those answers,” said Senator Schatz. “We are now one step closer to removing excessive barriers that make it difficult for researchers to study the effectiveness and safety of marijuana, and hopefully, give patients more treatment options.”

S.253 - Cannabidiol and Marihuana Research Expansion Act




















2022 House Bills






2022 Senate Bills

















“Until rigorous evidence about the benefits and risks of medical cannabis is available, policymakers must ensure that transparency and safety are prioritized to support patients and clinicians alike.”



Based upon a telephone conversation with the Elder of the Bible Questions Desk at the New York Headquarters on November 9, 2021, the medical use of cannabis that is authorized by a physician and being used under medical supervision does not constitute a scriptural violation and is considered a “personal choice”. The Elder recommended that members making this personal choice let their local Elder know so there is no misunderstanding within the community, but only if the member is comfortable sharing this confidential medical information.



State Attorney General Clare Connors said in oral arguments before the court last year that the state constitution mandated only that a bill have a broad enough title to encompass the changed content and that the bill be in its final form when it goes up for its last vote. She argued the Legislature needed flexibility to be able to substitute bill content to allow it to respond to unforeseen emergencies, like when it passed measures to respond to flooding on Kauai in 2019 and when it passed legislation to address the coronavirus pandemic in 2020.


Today is an important day for the State of California.  

Twenty-five years ago (November 5, 1996) California enacted Proposition 215, also known as the Compassionate Use Act, which created the first state authorization for the medical use of cannabis.  

We don’t know why California didn't work with the DEA to prevent a conflict with the federal regulation of marijuana.  Maybe because Prop 215 was enacted by voter initiative they figured it wasn’t worth the effort, or maybe they didn't realize that a solution exists. 

But the situation is very different in Hawaii, where our Medical Use of Cannabis Act was enacted via the legislative process, and we have a solution for the ongoing federal conflict that was unanimously adopted by both chambers of the Legislature last Session.  

Now we just need to follow through on HCR132, to protect our patients and prevent our state from falling prey to the false promises of recreational legalization.  





On Capitol Hill, the whispers of federal marijuana reform and legalization have grown into a clamor. But because of a lack of consensus among lawmakers and industry members, change is not on the immediate horizon, Walsh said.

"I'm still doubtful that we're going to see any significant federal reform next year ... including in banking," Walsh told CNN Business, referencing longstanding efforts to change federal law to allow state-legal cannabis businesses (and those that serve them) access to traditional banking services.

"I agree that it's an uphill slog to see federal legalization, but what we're putting on the table is inevitability," Steven Hawkins, CEO of the US Cannabis Council and executive director of the Marijuana Policy Project, said during a MJBizCon panel on federal legalization. "When you get to the point when half of the country has legalized for adult-use, we have now set a stage for inevitability. And that begins to change the tone and tenor in Washington."

















REQUESTING THE DEPARTMENT OF HEALTH TO APPLY TO THE DRUG ENFORCEMENT ADMINISTRATION'S OFFICE OF DIVERSION CONTROL FOR AN EXCEPTION UNDER TITLE 21 CODE OF FEDERAL REGULATIONS SECTION 1307.03, AND REQUEST FORMAL WRITTEN ACKNOWLEDGMENT THAT THE LISTING OF MARIHUANA, MARIHUANA EXTRACT, AND TETRAHYDROCANNABINOLS AS CONTROLLED SUBSTANCES IN FEDERAL SCHEDULE I DOES NOT APPLY TO THE PROTECTED ACTIVITIES IN HAWAII REVISED STATUTES.

HCR132 HD1 SD1 - Certified Copy - May 4, 2021

Letter to Governor Ige - Update on Federal Exemption - May 15, 2021



“The legislature further finds that allowing the medical use of marijuana could promote Hawaii as being an international center for medical treatment and research.”







Sec. 96. FEDERAL SCHEDULE I EXEMPTION APPLICATION FOR MEDICAL USE OF CANNABIS (Page 252). 

By September 1, 2021, the commissioner of health shall apply to the Drug Enforcement Administration's Office of Diversion Control for an exception under Code of Federal Regulations, title 21, section 1307.03, and request formal written acknowledgment that the listing of marijuana, marijuana extract, and tetrahydrocannabinols as controlled substances in federal Schedule I does not apply to the protected activities in Minnesota Statutes, section 152.32, subdivision 2, pursuant to the medical cannabis program established under Minnesota Statutes, sections 152.22 to 152.37. The application shall include the list of presumptions in Minnesota Statutes, section 152.32, subdivision 1.


Dr. Chanda Macias: “The states have really taken a proactive approach with protecting patients, which I adore. Now, federally, we need to lead the way. But also with that, I think about banking issues. What a lot of people don't know is that we can't use traditional banks in this space because it's still federally illegal.”




JMI-Web Image-03Apr21-3.jpg














Hawaii State Oath of Office

Article XVI, section 4, of the Hawaii constitution

All eligible public officers, before entering upon the duties of their respective offices, shall take and subscribe to the following oath or affirmation: "I do solemnly swear (or affirm) that I will support and defend the Constitution of the United States, and the Constitution of the State of Hawaii, and that I will faithfully discharge my duties as ____________ to the best of my ability."


Lion Reflection-3.jpg




















MOVING OMCCR TO EHA-Banner-1.jpg













REQUEST FOR INFORMATIONAL BRIEFING




Council on Developmental Disabilities - Executive Board Meeting - December 14, 2020








Keohokalole Banner-1.jpg


Federal Conflict-3.jpg

FEDERAL EXEMPTION PROPOSAL FOR 2021 SESSION



CB Header-1.jpg

SENATE COMMITTEE ON HEALTH HAS BEEN RESURRECTED !


Civil Beat Article on Recreational Cannabis - November 11, 2020

“Sen. Jarrett Keohokalole, who was recently named chairman of the Senate Health Committee, said he does plan to hold a hearing on a legalization bill in the legislative session that begins in January.”



NEW DOH DIRECTOR - LIBBY CHAR, MD


Char-Press Conference-16Sep20.jpg

First Press Conference as Director of DOH on September 16, 2020

"We need to make sure that we're paying attention to our health beyond COVID.”



RESURRECT THE SENATE COMMITTEE ON HEALTH



Resurrect HTH-5.jpg

Tulsi Gabbard-Banner-1.jpg

Ruderman Banner-1.jpg

2020 Legislative Session




329 Veteran Standown - Dr. Otto’s Presentation - September 14, 2019


2019 LEGISLATIVE SESSION


HCR89 - Requesting Congressional Action - PSM on 04/16/2019 - Testimony

GM543 - Relating to Nominee Espinda - PSM on 04/04/2019 - Testimony

HB673 HD2 SD1 - Relating to Medical Cannabis - JDC/WAM on 04/03/2019 - Testimony

SB1263 SD1 - Relating to the UCSA - JUD on 03/25/2019 - Testimony

HCR89 - Requesting Congressional Action - JUD on 03/22/2019 - Testimony

HB673 HD2 - Relating to Medical Cannabis - CPH on 03/21/2019 - Testimony

SB1263 SD1 - Relating to the UCSA - HLT on 03/21/2019 - Testimony

HB1383 HD2 - Relating to Marijuana - JDC on 03/19/2019 - Testimony

SB1353 SD3 HD1 - Relating to Industrial Hemp - JUD on 03/18/2019 - Testimony

HB290 HD1 - Relating to the UCSA - CPH on 03/15/2019 - Testimony

GM541 - Relating to Nominee Anderson - CPH on 2/25/2019 - Testimony

HB673 HD2 - Relating to Medical Cannabis - FIN on 02/21/2019 - Testimony

SB1263 - Relating to the UCSA - CPH on 02/20/19 - Testimony

HB131 HD2 - Relating to Hemp - FIN on 2/20/2019 - Testimony

SB541 - Relating to Medical Cannabis Products - CPH on 02/20/2019 - Testimony

SB1353 SD1 - Relating to Industrial Hemp - WAM on 02/19/19 - Testimony

HB673 HD1 - Relating to Medical Cannabis - JUD on 02/14/19 - Testimony

SB1266 - Relating to the UCSA - CPH on 02/13/19 - Testimony

HB131 HD1 - Relating to Hemp - JUD on 02/12/2019 - Testimony

HB290 - Relating to the UCSA - JUD on 02/07/2019 - Testimony

SB527 - Relating to Cannabis for Medical Use - CPH on 02/06/19 - Testimony

HB131 - Relating to Hemp - AGR on 02/06/2019 - Testimony

HB673 - Relating to Medical Cannabis - HLT on 02/05/19 - Testimony

SB1335 - Relating to Hemp - AEN on 02/04/19 - Testimony

SB686 - Relating to Marijuana - JDC on 01/31/19 - Testimony


NTJ-Inter-island Transportation-10Jul19.jpg


HNN-Bill Veto Looming-08Jul19.jpg


CC-Discrimatory Practices-03Jul19.jpg



FDA Call for Comments on CBD - Testimony - May 28, 2019


DOJ Marijuana Summit - March 28, 2019 - Agenda - Dr. Otto’s Presentation












Cannabis Chronicles-11Dec17-1.jpg

ThinkTech-image-4Oct17.jpg

APPEARANCES



ONLINE ARTICLES



NEWSPAPER MENTIONS



LETTERS TO THE EDITOR



PRESENTATIONS


John Burns School of Medicine - Medical Cannabis: What's the Evidence ? - CME event - November 4, 2017




ARTICLES IN PRINT



Clifton Otto, MD

Available by appointment for Confidential Medical Consultation.  

808-233-8267